BetterLife Pharma is a life sciences company that aims to develop ‘second generation’ psychedelics that provide therapeutic benefits without the trip.
BetterLife Pharma
From the homepage: “BetterLife Pharma Inc. is a life sciences company creating and clinically validating an evolving intellectual property portfolio of novel molecules and drug delivery mechanisms for clinical trials and commercialization.“
The company acquired Transcend Biodynamics in late 2020 to have a way of producing BOL-148, a non-psychedelic LSD-derivative, without requiring scheduled substances.
BetterLife Pharma has raised $21.89 million over 5 rounds as of March 2021.
The company is listed on the CNSX under the ticker BETR.
News
- BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC (press release, December 2020)
Activities
B2B
B2C
Biotech
Drug Discovery
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates